FG5-16821-94303
2 vaccinations
3 coded responses
19 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 641 / MO
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
-
2020-12-19
Survey response — days 1–6 daily, dose 1MedDRA: Hypogeusia, Injection site pain — Feeling: Good · Site: PainFree text: Soreness at injection site, food has decreased tasteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-20
- 2020-12-21
- 2020-12-27
- 2021-01-01
-
2021-01-07
Dose 2 — Pfizer-BioNTech
-
2021-01-07
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Vomiting · Be unable to workAdult check-in
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-16
- 2021-01-21
- 2021-01-28
- 2021-02-07
-
2021-02-17
Survey response — day 35, dose 2MedDRA: Cough, Nasal congestion, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Nasal congestion, runny nose, sore throat, coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-01-07
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Soreness at injection site, food has decreased taste
Release 4 — day 35, dose 2
Symptoms: Nasal congestion, runny nose, sore throat, cough
Release 10 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Hypogeusia | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release